(TheNewswire)
MISSISSAUGA, Ontario - TheNewswire - March 17, 2021 - Sire Bioscience Inc.(C NSX :SIRE. CN ) (OTC:BLLXF)(FSE:BR1B) (“ SIRE ” or the“ Company ”) is pleased to report that, despite the COVID-19 globalpandemic, mass gym closures and limited capital to grow its businessline, sales from its Fusion line of products has increased 9% yearover year from February 2020 to February 2021. Additionally, theCompany is proud that that Fusion’s “Purple K” is now Canada’snumber one selling creatine pill.
Brian Polla, CEO and a director of the Companycommented: “The past year has been challenging for everyone and weare tremendously proud of the Company’s accomplishments. Personally, I have supported the growth of the Company by continuingto invest through open market purchases of shares and participation inthe private placement financing of the Company. We would like tothank the Company’s shareholders and investors who have alsosupported our growth. With the recent acqui sition of PlantFuel, Inc. and capital raises of over$5,000,000 in the past two months, we are now well positioned to growout the Fusion business line and to market the PlantFuel productofferings.”
Brian Polla added “Our management team has foundstrategic ways to improve sales and build on our working relationshipswith our clients. We intend to continue to build on our successesand are both enthusiastic and strongly encouraged by the earlyreception from retailers in the United States about the anticipatedroll-out of the PlantFuel product lines. The Company is extremelyoptimistic about its future.”
The Canadian Securities Exchange(“CSE”) has neither approved nor disapproved the contents of thisnews release. Neither the CSE nor its Market Regulator (as that termis defined in the policies of the CSE) accepts responsibility for theadequacy or accuracy of this release.
About Sire Bioscience
SIRE is headquartered in Mississauga, Ontario with itswholly owned subsidiary PLANTFUEL® based inDenver, Colorado. SIRE is managed by a groupof successful entrepreneurs who have extensive experience in the areasof consumer-packaged goods, manufacturing, logistics, anddistribution. SIRE is a CPG life science company focused on theplant-based foods and supplements industry.
For additional informationcontact:
Sire Bioscience Inc.
Website: sirebioscience.com
Socials: @sirebioscience
Forward?Looking InformationCautionary Statement
This press release may contain certain“forward-looking information” and “forward-looking statements”within the meaning of applicable Canadian securities legislation. Allinformation contained herein that is not historical in nature mayconstitute forward-looking information. Forward-looking statements maybe identified by statements containing the words “believes”,“anticipates”, “plans”, “intends”, “will”,“should”, “expects”, “continue”, “estimate”,“forecasts” and other similar expressions. Forward-lookingstatements herein include, but are not limited to, expectations ofmanagement’s focus on and growth expectations of the Fusion andPlantFuel product lines, the products of PlantFuel to be madeavailable and the timing thereof, and the Company’s business andstrategic plans. Readers are cautioned to not place undue reliance onforward-looking information. Actual results and developments maydiffer materially from those contemplated by these statements.undertakes no obligation to comment analyses, expectations orstatements made by third parties in respect of SIRE, its securities,or financial or operating results (as applicable). Although SIREbelieves that the expectations reflected in forward-looking statementsin this press release are reasonable, such forward-looking statementhas been based on expectations, factors and assumptions concerningfuture events which may prove to be inaccurate and are subject tonumerous risks and uncertainties, certain of which are beyond SIRE’scontrol, including the risk factors discussed in SIRE’s ListingStatement dated August 22, 2019 which is available on SIRE’s SEDARprofile at www.sedar.com . The forward-looking information contained in this pressrelease is expressly qualified by this cautionary statement and aremade as of the date hereof. SIRE disclaims any intention and has noobligation or responsibility, except as required by law, to update orrevise any forward-looking information, whether as a result of newinformation, future events or otherwise.
Copyright (c) 2021 TheNewswire - All rights reserved.